Company facts
- Headquarters
- South San Francisco, California
- Most recent report
- 8-K, filed Oct 15, 2026
- Incorporated
- Delaware
- Filings on record
- 363 filings
- On EDGAR
- CIK 1854270
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 26
News 8 of 77
Prospectuses and Registrations 8 of 62
- 424B3 Prospectus supplement for an offering Sep 24, 2026
- S-3/A Shelf registration statement, amended Sep 22, 2026
- S-3/A Shelf registration statement, amended Sep 10, 2026
- S-3/A Shelf registration statement, amended Jul 16, 2026
- S-3 Shelf registration statement Jun 18, 2026
- 424B5 Prospectus supplement for an offering May 1, 2026
- S-8 Registration statement for an employee plan Apr 24, 2026
- S-8 POS Post-effective amendment to an employee plan registration Apr 24, 2026
Proxies 8 of 17
Ownership 8 of 126
- SCHEDULE 13D/A Large holder reported an active stake, amended Sep 11, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jul 16, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended May 4, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Apr 16, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Mar 31, 2026
- 4 Insider reported a trade Mar 11, 2026
- 4 Insider reported a trade Mar 11, 2026
- 4 Insider reported a trade Feb 3, 2026
Other 8 of 55
- EFFECT Notice that a registration became effective Sep 24, 2026
- PRER14A Sep 24, 2026
- PRER14A Sep 4, 2026
- ARS Annual report sent to shareholders Jul 21, 2026
- D Jun 4, 2026
- 15-12G May 8, 2026
- EFFECT Notice that a registration became effective Apr 29, 2026
- EFFECT Notice that a registration became effective Apr 29, 2026
Everything here comes from Senti Biosciences Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.